Showing results (1291-1300 of 2,232) with videos related to
Sort By:
Pageof 224
Cancer Biotherapy & Radiopharmaceuticals|June 13, 2000
Expression of adhesion molecules in B-cell chronic lymphocytic leukaemia: an analysis in lymphoid compartments--peripheral blood, bone marrow and lymph nodeJ J Nadkarni, S M Perambakam, V B Rathore, et al.Cancer Biotherapy & Radiopharmaceuticals|June 13, 2000
Susceptibility of natural killer (NK) cells to reactive oxygen species (ROS) and their restoration by the mimics of superoxide dismutase (SOD)K Nakamura, K MatsunagaCancer Biotherapy & Radiopharmaceuticals|June 14, 2000
Loss of VLA-3 (CD49c/CD29) expression in two multidrug resistant Burkitt's lymphoma cell linesS Duensing, A Duensing, J Grosse, et al.Cancer Biotherapy & Radiopharmaceuticals|June 14, 2000
99mTc-ethylenedicysteine-folate: a new tumor imaging agent. Synthesis, labeling and evaluation in animalsS Ilgan, D J Yang, T Higuchi, et al.Cancer Biotherapy & Radiopharmaceuticals|June 14, 2000
Suppression by radiosensitizer AK-2123 of early phorbol myristate acetate-stimulated chemiluminescence response of human neutrophils induced by gamma-irradiation (short communication)I SchepetkinCancer Biotherapy & Radiopharmaceuticals|February 1, 1997
Hybrid high-dose bolus/continuous infusion interleukin-2 in patients with metastatic renal cell carcinoma: a phase II trial of the National Biotherapy Study GroupR O Dillman, M C Wiemann, M J Bury, et al.Cancer Biotherapy & Radiopharmaceuticals|August 1, 1997
Long-term survival after continuous infusion interleukin-2R O Dillman, C Church, N M Barth, et al.Cancer Biotherapy & Radiopharmaceuticals|August 1, 1997
The sCEA molecule suppressive role in NK and TH1 cell functions in colorectal cancerP Pellegrini, A M Berghella, T Del Beato, et al.Cancer Biotherapy & Radiopharmaceuticals|August 1, 1997
Antitumor effect of anthocyanin fractions extracted from red soybeans and red beans in vitro and in vivoT Koide, Y Hashimoto, H Kamei, et al.Cancer Biotherapy & Radiopharmaceuticals|June 14, 2000
Pilot ascending dose tolerance study of parenterally administered 4-(2 hydroxyethyl)-1-piperazine ethane sulfonic acid (TVZ-7) in dogsT R Theodore, R L Van Zandt, R H CarpenterPageof 224